Misoprostol for pregnancy loss in second trimester
Part of Women’s health & pregnancy clinical trials.
This trial tests a medication called misoprostol to help the body expel pregnancy tissue after a fetal death between 18 and 24 weeks. It may be an option for women who have not had a previous C-section or have had only one.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 40 years old.
- Your pregnancy is between 18 and 24 weeks and the baby has died (missed abortion).
- Your cervix is not ready for labor (Bishop score less than 5).
- You have had either no previous C-section or only one previous C-section.
- You do not have severe health problems like severe anemia, uncontrolled high blood pressure, diabetes, or a bleeding disorder.
- You are not allergic to misoprostol or similar medicines, and do not have severe asthma.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether taking an aromatase inhibitor (letrozole) before misoprostol helps complete a miscarriage more effectively. It may offer a treatment option for people with a missed or early pregnancy loss.
This trial tests two different medicines (Mifepristone vs Misoprostol) to see which works better for ending a pregnancy in the second trimester (12–16 weeks). It is for people who are pregnant with one baby and have no major health issues that could affect safety.
This study compares two medications—letrozole plus misoprostol versus misoprostol alone—to see which is more effective for ending a pregnancy in the second trimester (14–20 weeks) after the fetus has stopped developing. The goal is to find a safer, more comfortable method for women who need this procedure.
This trial tests if giving a medication called misoprostol as a rectal suppository can help reduce bleeding during a planned cesarean section. If you are having a planned cesarean and are generally healthy, this study might be an option for you.
This study compares two ways of taking medicine (by mouth or vaginal insertion) to safely manage a miscarriage that was discovered on ultrasound between 8–16 weeks of pregnancy. The goal is to see which method works better and causes fewer side effects.
This trial tests if giving misoprostol before a planned c-section can help reduce bleeding. It might make the surgery safer for women who meet certain criteria.
Hear when a new Abortion; Attempted trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.